Supernus Pharmaceuticals, Inc.
SUPN· Nasdaq
SUPNSupernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.’s Q3 2026 10-Q window runs Nov 2, 2026 to Nov 9, 2026.
Based on 8 prior 10-Q filings.
Supernus Pharmaceuticals, Inc. · CIK 1356576 · Engraved from SEC EDGAR
